Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
1.100
+0.145 (15.12%)
At close: Jul 6, 2026, 4:00 PM EDT
1.130
+0.030 (2.73%)
Pre-market: Jul 7, 2026, 5:43 AM EDT
Onconetix Employees
Onconetix had 2 employees as of December 31, 2025. The number of employees decreased by 3 or -60.00% compared to the previous year.
Employees
2
Change (1Y)
-3
Growth (1Y)
-60.00%
Revenue / Employee
$367,599
Profits / Employee
-$5,014,918
Market Cap
4.06M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2 | -3 | -60.00% |
| Dec 31, 2024 | 5 | -7 | -58.33% |
| Dec 31, 2023 | 12 | 0 | - |
| Dec 31, 2022 | 12 | 7 | 140.00% |
| Dec 31, 2021 | 5 | - | - |
| Sep 30, 2021 | 2 | - | - |
| Jun 30, 2021 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Calidi Biotherapeutics | 29 |
| GeoVax Labs | 19 |
| Decoy Therapeutics | 11 |
| Ensysce Biosciences | 10 |
| Revelation Biosciences | 9 |
| Artelo Biosciences | 7 |
| Galmed Pharmaceuticals | 6 |
| GRI Bio | 4 |
ONCO News
- 12 days ago - Onconetix Highlights Realbotix's Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District - GlobeNewsWire
- 17 days ago - Onco-Innovations Announces Non-Brokered LIFE Offering - Accesswire
- 17 days ago - Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development - Accesswire
- 20 days ago - Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization - Accesswire
- 27 days ago - Onconetix Registration statement: Registration filing - Filings
- 4 weeks ago - Onconetix files to sell 100M shares of common stock for holders - TheFly
- 6 weeks ago - Onconetix Inc trading halted, news pending - TheFly
- 6 weeks ago - Onconetix announces 1-for-10 reverse stock split - TheFly